Company Filing History:
Years Active: 2017
Title: Mark Kinch: Innovator in Pharmaceutical Chemistry
Introduction: Mark Kinch is a notable inventor based in San Diego, California, who has made significant contributions to the field of pharmaceutical chemistry. His innovative work focuses on halogenated indole and benzofuran derivatives, showcasing his expertise in developing processes for the preparation of complex chemical compounds.
Latest Patents: Mark Kinch holds a patent for "Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them." This patent outlines the methods for synthesizing halogenated derivatives, including enantioselective processes for producing both (-) and (+) noribogaine in substantially enantiomerically pure forms. This invention presents valuable advancements in pharmaceutical formulations.
Career Highlights: Mark is currently working at Demerx, Inc., where he applies his expertise in chemistry to develop innovative solutions. With a strong focus on research and development, he continues to contribute to the advancement of pharmaceutical products and processes.
Collaborations: Throughout his career, Mark Kinch collaborates with esteemed professionals in the industry, including his coworker Robert M. Moriarty. Together, they push the boundaries of chemical research and development, leading to groundbreaking inventions and improvements in pharmaceutical applications.
Conclusion: Mark Kinch has established himself as a prominent inventor in the realm of pharmaceutical chemistry. His patent on halogenated indole and benzofuran derivatives exemplifies his commitment to innovation and the development of effective medicinal compounds. As he continues to work at Demerx, Inc., his contributions remain vital to the evolution of the pharmaceutical industry.